BCS Classification in Dissolution Method Development

BCS Classification in Dissolution Method Development

Introduction: BCS classification (Biopharmaceutics Classification System) is an important concept in pharmaceutical development because it connects the solubility and permeability of a drug substance with its expected absorption and dissolution behaviour.

A highly soluble drug may dissolve rapidly, while a poorly soluble drug may require more carefully designed dissolution conditions. Similarly, permeability influences whether dissolution or membrane transport is more likely to control drug absorption.

The BCS divides drug substances into four classes based on aqueous solubility and intestinal permeability.

What Is BCS Classification?

The Biopharmaceutics Classification System classifies drug substances into four categories:

BCS Class	Solubility	Permeability	Major Concern
Class I	High	High	Usually dissolution is not rate-limiting
Class II	Low	High	Dissolution may limit absorption
Class III	High	Low	Permeability may limit absorption
Class IV	Low	Low	Both dissolution and permeability can be problematic

The classification is based mainly on two fundamental drug properties: Solubility and Permeability

However, BCS classification should not be confused with the dissolution classification of a finished pharmaceutical product. BCS primarily describes the drug substance, while dissolution testing evaluates the performance of the drug product.

1. BCS Class I – High Solubility and High Permeability

BCS Class I drugs have: High solubility, High permeability

These drugs generally have favourable oral absorption characteristics.

For ICH M9, a drug substance is considered highly soluble when the highest single therapeutic dose is completely soluble in 250 mL or less of aqueous media over pH 1.2–6.8 at 37 ± 1°C.

Dissolution method development for BCS Class I

Because the drug is highly soluble and highly permeable, dissolution may not be the major absorption limitation.

During development, the analyst should nevertheless evaluate:

• Apparatus selection
• Dissolution medium
• pH
• Agitation speed
• Sampling time
• Drug-product disintegration
• Formulation sensitivity
• Discriminatory capability of the method

A rapidly dissolving product may require shorter sampling intervals because a conventional 15- or 30-minute sampling interval could miss the actual dissolution behavior.

For highly soluble immediate-release products, regulatory guidance may permit simpler approaches when appropriate data demonstrate rapid dissolution and product performance.

2. BCS Class II – Low Solubility and High Permeability

BCS Class II drugs have: Low solubility, High permeability

This is one of the most important BCS categories for dissolution method development.

cause permeability is high, but the drug does not dissolve easily. Therefore, dissolution can become the rate-limiting step for absorption.

A multiple-media dissolution profile can be particularly useful during development to understand the behavior of the formulation under different conditions.

For example, development may evaluate:

• Acidic medium
• pH 4.5 buffer
• pH 6.8 buffer
• Water, where justified
• Surfactant-containing media, when scientifically justified

The objective should not simply be to obtain high dissolution. The method should ideally be discriminating, meaning that it can detect meaningful formulation or manufacturing differences.

3. BCS Class III – High Solubility and Low Permeability

BCS Class III drugs have: High solubility, Low permeability

In this class, the drug dissolves relatively easily, but intestinal permeability can limit absorption.

Therefore, dissolution may be less likely to control systemic exposure than it is for a BCS Class II drug.

For rapidly dissolving products, a simple dissolution test may sometimes provide sufficient control, provided that development data demonstrate appropriate product performance.

ICH M9 recognizes BCS Class III as one of the classes potentially eligible for a BCS-based biowaiver when the other requirements are satisfied.

4. BCS Class IV – Low Solubility and Low Permeability

BCS Class IV drugs have: Low solubility, Low permeability

This is generally the most challenging BCS category for oral drug development.

Both dissolution and permeability can restrict absorption.

For such compounds, dissolution testing should be developed carefully rather than selecting conditions only because they produce nearly 100% dissolution.

A method that gives 100% dissolution for every formulation may actually have poor discriminatory power.

How BCS Classification Helps in Dissolution Method Development

BCS classification provides a scientific starting point, but it should not be the only factor used to select dissolution conditions.

Step 1: Determine the BCS Class

Review available data for: Solubility, Permeability, Dose, pH-solubility profile

For ICH M9-based assessment, solubility is evaluated across the pH range of 1.2–6.8, including pH 1.2, 4.5 and 6.8, with additional evaluation at the pH of minimum solubility when applicable.

Step 2: Understand the Drug’s Solubility Profile

Determine whether the drug is: Freely soluble, Soluble, Sparingly soluble, Poorly soluble

Also determine whether solubility changes significantly with pH.

This is particularly important for ionizable drugs.

Step 3: Select the Dissolution Medium

The medium should be selected based on the drug’s physicochemical properties and intended purpose of the method.

Consider: pH, Buffer capacity, Ionic strength, Surfactant, Enzyme, where justified, Volume, Sink conditions

Avoid adding surfactant simply to achieve high dissolution without scientific justification.

Step 4: Select Apparatus and Agitation Speed

Common dissolution apparatus include:

• USP Apparatus 1 – Basket
• USP Apparatus 2 – Paddle

Step 5: Generate a Dissolution Profile

Instead of relying only on one time point during development, collect multiple samples.

For example: 5, 10, 15, 20, 30, 45, 60 and 90 minutes

The actual sampling schedule should be adapted to the drug and formulation.

Fast-dissolving products may require early sampling, while slow-release or poorly soluble products may require longer observation.

Step 6: Evaluate Discriminatory Power

This is a critical part of dissolution method development.

A good dissolution method should be capable of detecting meaningful changes in:

• API particle size
• Compression force
• Disintegrant level
• Binder level
• Lubricant level
• Granulation process
• Coating
• Manufacturing process

The method should not be unnecessarily harsh if the purpose is to understand formulation performance.

FDA notes that dissolution procedures should be product-specific and that method selection and acceptance criteria should be supported by dissolution data for the proposed product.

BCS classification is a valuable tool for understanding the relationship between drug solubility, permeability, dissolution and oral absorption.

FAQs on BCS Classification for Dissolution Method Development.

• What is BCS classification? — BCS classifies drug substances based on their solubility and intestinal permeability.
• What are the four BCS classes? — BCS Class I, II, III and IV are based on combinations of high/low solubility and permeability.
• What is BCS Class I? — BCS Class I drugs have high solubility and high permeability.
• What is BCS Class II? — BCS Class II drugs have low solubility and high permeability, making dissolution particularly important.
• What is BCS Class III? — BCS Class III drugs have high solubility and low permeability.
• What is BCS Class IV? — BCS Class IV drugs have low solubility and low permeability and may present challenges in oral absorption.
• What is the difference between solubility and permeability? — Solubility determines whether a drug dissolves, while permeability determines whether the dissolved drug can cross the intestinal membrane.
• How does BCS classification help in dissolution method development? — It helps identify whether solubility and dissolution may be important factors affecting drug absorption.
• Which BCS class generally requires more attention during dissolution development? — BCS Class II generally requires particular attention because of its low solubility and high permeability.
• Does BCS classification alone determine the dissolution method? — No, the final dissolution method should be based on drug properties, formulation characteristics and experimental development data.